Director sold ~$10.1M of Charles River Laboratories
Scheduled in advanceCRL · NYSE · Life Sciences Tools & Services
Life Sciences Tools & Services company based in Wilmington, Massachusetts.
Last close, Oct 1, 2026
$286.83
Adjusted for splits and dividends
Last 12 months
+68.3%
S&P 500 +14.3% over the same dates
Market value
$13.7B
Last close × shares outstanding
Bets against the stock: 2.23M shares sold short (4.7% of shares outstanding), -12.0% vs the previous count, 2.8 days of normal trading to buy them back. FINRA, as of Sep 15, 2026.
Insiders buying, last 90 days
None
No open-market purchases reported
Insiders selling, last 90 days
17 sales
$25.7M sold. Insiders sell for many reasons.
New federal contracts, 12 months
None
Nothing found for this company
Revenue, fiscal 2025
$4.02B
-0.9% vs the year before
Net income, fiscal 2025
-$144M
A loss for the year
Shares outstanding
47.7M
As of Jul 25, 2026
In fiscal 2025 the company spent $361M buying back its own shares. Cash actually paid, from its cash-flow statement.
Director sold ~$10.1M of Charles River Laboratories
Scheduled in advanceStock since the trade +2.7% · S&P 500 -0.5% · to Oct 1Traded 13 days after resultsStock within 3% of its 52-week high, after a 22% rise in the previous month
2,011 → 1,438 shares held−28% of their stake
A board member of Charles River Laboratories sold $163K of Charles River Laboratories shares. Nobody planned it ahead of time.
Officer sold ~$600K of Charles River Laboratories
Scheduled in advanceFrom a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
CEO sold ~$1.82M of Charles River Laboratories
Scheduled in advancePrices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Short sale volume: 54.0% of the volume reported to FINRA over the last 20 trading days was marked short, below its 1-year average of 60.6%. FINRA daily files, to Oct 2, 2026.
Fails to deliver: 4,984 shares (about $1.48M) were not delivered on time for settlement on Aug 26, 2026. SEC fails-to-deliver data.
Short sale volume is not short interest. It counts trades marked short, including market makers selling short to fill buy orders, so it is a share of daily trading, not a count of bets against the stock. Fails to deliver have many causes, including processing delays, and are often resolved within days.
Last 12 months, adjusted daily closes
Adjusted close went from $170.48 on Oct 1, 2025 to $286.83 on Oct 1, 2026 (+68.2%). Disclosed trades in the last 12 months: 1 insider purchase, 18 insider sales (7 under pre-arranged plans), 0 Congress purchases, 0 Congress sales.
1 notice filed with state agencies, covering 94 workers in total. Employers must warn the state ahead of a plant closing or mass layoff at a site.
Official WARN lists from California, Texas, New York, Florida, Illinois and Washington only; notices filed in other states are not shown. Matched on the employer name as filed, so a notice filed under an unrelated subsidiary name can be missing. Dates are the notice date (Washington: the date the state received it).
19 certified in FY2026 Q3, vs 15 a year earlier. 19 positions in total, median offered wage $106K a year.
Labor condition applications for H-1B workers certified by the Department of Labor, counted by decision date (FY2026 Q3: Apr 1, 2026 to Jun 30, 2026, the latest quarter published). A certified application is a step before a visa petition, not a hire or a visa, and one application can cover several positions. Matched by employer ID number or name.